Annual Reporting Suite

Annual Report and US Securities & Exchange Commission Form 20-F

These reports, filed with the SIX Swiss Exchange in Switzerland and the US Securities and Exchange Commission in the US, provide a comprehensive overview of Novartis, including our company structure, corporate governance and compensation practices. They also disclose our operating and financial results, accompanied by audited annual financial statements.

XBRL package

View the Novartis Form 20-F in XML format in line with requirements of the SEC.

Novartis in Society ESG Report

The Novartis in Society ESG Report details progress on environmental, social_and governance topics and demonstrates the company’s commitment in global health and corporate responsibility.

Annual Review 2020

The Annual Review explains who we are and what we do, and highlights our progress against the company’s five strategic priorities in 2020.